Welcome
- Overview
- Faculty Profiles and Interests
- Support Personnel
- Laboratory Facilities
- NEWS & Announcements
- 2009-2010 Seminar Series
- 2010-2011 Seminar Series
- 2011-2012 Seminar Series
- 2012-2013 Seminar Series
- Graduate Programs
- Current Students
- Student-Faculty Publications
- Recruitment
Rocket Science
About UT - Map to UT Health Science Campus
Related Links
- Cancer Biology Track
- 2011 Midwest DNA Symposium
- 2011 Graduate Research Forum
- 2010 Graduate Research Forum
- 2010 UT-COM Research Day
- Cancer Center
- Electron Microscopy Facility
- Flow Cytometry Core Lab
- Genomics Core Lab
- Advanced Microscopy & Imaging Center
Contact Us
Health Science Campus, Mail Stop #1010
3000 Arlington Avenue
Toledo, OH 43614
419-383-4131 phone
419-383-6228 fax
John David Dignam, Ph.D.
![]() |
John David Dignam, Ph.D. Professor of Biochemistry and Cancer Biology David.Dignam@utoledo.edu |
RESEARCH INTERESTS:
The research of my laboratory is focused on nucleic acid enzymology, nucleic acid protein interaction
and more recently on the development of modified human albumin for the treatment of shock.
Aminoacyl tRNA synthetases are a class of
enzymes that ensure the fidelity of protein synthesis by attaching amino acids to their cognate tRNAs. Studies of the thermodynamics
of
binding of ligands to glycyl tRNAs suggest that the formation of glycyl adenylate, an obligate intermediate on the reaction
pathway, is
accompanied by a significant conformation change in the protein that alters the affinity of the enzyme for tRNA. We are extending
these
studies to alanyl-tRNA synthetase, an enzyme with editing activities for both noncognate adenylates (glycyl- and seryl-adenylates)
and for
misacylated tRNAala (acylated with serine or glycine). Our thinking is that enzyme ligated with the noncognate adenylate will
have reduced affinity for tRNAala, resulting in a reduction in misacylation with serine or glycine and increased specificity.
Adenoassociated
virus 2, a nonpathogenic parvovirus, has attracted interest as a potential gene therapy vector. It has a small (4500 nucleotides)
genome
that encoding four DNA helicases that are required for viral DNA replication and efficient packaging of single stranded DNA
into virions.
Rep78, Rep68, Rep52 and Rep40 share common structural elements in their helicase domains, but differ at their N-termini and
C-termini as a result
of differential splicing and different mRNAs arising from the use of different transcription start sites. The larger Rep
proteins, Rep78
and Rep68, assemble into stable, hexameric oligomers on specific secondary structures on the 3’ and 5’ termini of the single
stranded
viral DNA. Rep78 and Rep68 also have a site specific nuclease activity, residing in an N-terminal structure, that creates
a priming
site in the template for DNA replication. The smaller replication proteins, Rep40 and Rep52, require ATP to bind DNA, show
no sequence
specificity in DNA binding and lack the N-terminal nuclease domains. Rep52 and Rep40 are implicated in packaging plus and
minus single
stranded DNA into virions. Our studies are aimed at understanding how these proteins assemble on DNA structures and the specificity
of
their interaction with DNA.
A third project is the development of a modified form of human albumin as a treatment for hypovolemia
resulting from increased permeability of capillaries that occurs in shock. Increased permeability of capillaries (also called
capillary
leak) to macromolecules, such as albumin, occurs in number of clinical conditions including sepsis and trauma. Albumin extravasates
into
the extracellar space with a resulting loss of the oncotic gradient that draws water back from tissues into blood vessels.
We have
demonstrated that polyethylene glycol-modified albumin is effective in animal models of sepsis and hemorrhagic shock in improving
organ perfusion
and maintaining blood pressure. The rationale behind using polyethylene glycol-modified albumin is that this modified protein
has a
sufficiently large hydrodynamic radius that precludes its passing through defects in capillaries that occur in shock and is
thus retained within
blood vessels to maintain the oncotic gradient.
Member of the mentoring faculty for the Biomedical Sciences Graduate Program (Cancer Biology Track).
EDUCATION:
Ph.D.
1977 University of Texas College of Graduate Studies of Biomedical Sciences (Biochemistry)
B.S. 1972 University of Houston (Microbiology)
ACADEMIC
APPOINTMENTS:
2004 - pres. Professor, Biochemistry and Cancer Biology, University of Toledo College of
Medicine
1988 - 2004 Associate Professor, Biochemistry and Molecular Biology, Medical University of Ohio
1982 - 1988 Assistant Professor,
Biochemistry, The University of Mississippi
1980 - 1982 Postdoctoral Fellow, Biological Chemistry, Washington University
1977 - 1980
Postdoctoral Fellow, Biochemistry, University of Connecticut
REPRESENTATIVE PUBLICATIONS:
Assaly, R.A., Habib,
R.H., Azizi, M., Shapiro, J.I. and Dignam, J.D. (2008) Use of multiple fluorophores for evaluating microvascular permeability
in control and
septic rats. Clin. Sci. (Lond.) 114:123-130.
Dignam, S., Collaco, R.F., Bieszczad, J., Needham, P., Trempe, J.P. and
Dignam, J.D. (2007) Coupled ATP and DNA binding of adeno-associated virus Rep40 helicase. Biochemistry 46:568-576.
Needham,
P.G., Casper, J., Dignam, J.D. and Trempe, J.P. (2006) Characterization of adeno-associated virus Rep protein-mediated inhibition
of
transcription of the adenovirus major late promoter in vitro. J. Virology 80:6207-6217.
Timpe, J., Bevington, J.,
Casper, J., Dignam, J.D. and Trempe, J.P. (2005) Mechanisms of adeno-associated virus genome encapsidation. Current Gene Therapy
5:273-285.
Casper, J., Timpe, J., Dignam, J.D. and Trempe, J.P. (2005) Identification of an adeno-associated virus Rep protein binding
site in the adenovirus E2a promoter. J. Virology 79:28-38.
Sampath, P., Mazumder, B., Seshadri, V., Gerber, C.A.,
Chavatte, L., Kinter, M., Ting, S.M., Dignam, J.D., Kim, S., Driscoll, D.M. and Fox, P.L. (2004) Noncanonical function of
glutamyl-prolyl-tRNA
synthetase: gene-specific silencing of translation. Cell 119:195-208.
Assaly, R.A., Azizi, M., Kennedy, D.J.,
Amauro, C., Zaher, A., Houts, F.W., Habib, R.H., Shapiro, J.I. and Dignam, J.D. (2004) Plasma expansion by polyethylene-glycol-modified
albumin.
Clin. Sci. (Lond.) 107:263-272.
Collaco, R.F., Kalman-Maltese, V., Smith, A.D., Dignam, J.D. and Trempe,
J.P. (2003) A Biochemical Characterization of the Adeno-Associated Virus Rep40 Helicase. J. Biol. Chem. 278(36):34011-34017.
Dignam, J.D., Nada, S. and Chaires, J.B. (2003) Thermodynamic Characterization of the Binding of Nucleotides to Glycyl-tRNA
Synthetase. Biochemistry
42(18):5333-5340.
Dignam, J.D., Qu, X. and Chaires, J.B. (2001) Equilibrium Unfolding of Bombyx mori Glycyl-tRNA
Synthetase. Journal Biol. Chem. 276(6):4028-4037.
Trempe Norcum, M. and Dignam, J.D. (1999) Immunoelectron
Microscopic Localization of Glutamyl-/ Prolyl-tRNA Synthetase within the Eukaryotic Multisynthetase Complex. Journal Biol. Chem.
274(18):12205-12208.
Ren, J., Qu, X., Chaires, J.B., Trempe, J.P., Dignam, S.S. and Dignam, J.D. (1999)
Spectral and Physical Characterization of the Inverted Terminal Repeat Structure of Adenoassociated Virus 2. Nucl. Acids Res. 27
(9):1985-1990.
UT Virtual View Book
UT Rockets
A University Rising
UTMC Named Regions #1 Hospital
